<DOC>
	<DOCNO>NCT00271063</DOCNO>
	<brief_summary>This Phase I/II multi-center , open label , dose escalation study identify maximum tolerate dose ( MTD ) liposomal annamycin evaluate safety liposomal annamycin patient refractory relapse acute lymphocytic leukemia .</brief_summary>
	<brief_title>Study Liposomal Annamycin Patients With Refractory Relapsed Acute Lymphocytic Leukemia</brief_title>
	<detailed_description>This Phase I/II , multi-center , open-label , dose escalation , MTD study liposomal annamycin refractory relapse ALL patient . Enrollment occur cohort approximately 3 patient 10 additional patient enrol MTD . The liposomal annamycin dos escalate sequential cohort . Four dose level liposomal annamycin plan : 190 , 230 , 280 , 310 mg/m2/day .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Annamycin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<criteria>Diagnosis refractory relapse ALL ( acute lymphocytic leukemia ) Age great equal 15 year No chemotherapy , radiation , major surgery within 2 week prior first dose study drug recover toxic side effect therapy , unless treatment indicate due progressive disease . No investigational therapy within 4 week first dose study drug ECOG performance status ( PS ) 0 2 . Adequate liver function Adequate renal function Signed informed consent Concommitant therapy include chemotherapy may active ALL ( except central nervous system [ CNS ] therapy ) Any condition opinion investigator , place subject unacceptable risk he/she participate study . Cardiac ejection fraction le 40 % Clinically relevant serious comorbid medical condition . Pregnant , lactate use adequate contraception . Known allergy doxorubicin anthracyclines .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Refractory Relapsed Acute Lymphocytic Leukemia</keyword>
</DOC>